News + Font Resize -

Molecular Connections to aid Triesta Sciences in biomarker discovery
Our Bureau, New Delhi | Wednesday, April 23, 2003, 08:00 Hrs  [IST]

Bangalore based Molecular Connections Pvt. Ltd. has entered into a strategic alliance with Triesta Sciences, a clinical genomics company based in Menlo Park in the area of biomarker discovery and validation. As a part of the alliance, the company is to provide its advanced information extraction, informatics and pathway analysis expertise for Triesta Sciences' biomarker discovery programme.

Commenting on the alliance, Jignesh Bhate, founder and director of Molecular Connections said that he is ““pleased to be working with Triesta in their efforts to identify novel biomarkers in clinical samples".

Molecular Connections' powerful information extraction technologies and analysis tools help biopharmaceutical scientists to efficiently navigate, integrate and analyze data from various unstructured and structured sources.

Molecular Connections is a joint venture between Idea2solutions Private Limited an incubator promoted by the founders of the Dr Reddy's group and Laboratories for Information Technology Singapore, a national research institute for advanced technologies.

According to a company release, Molecular Connections' initial focus is to build state-of-the-art products and provide world-class services to enhance efficiency, reduce the discovery cycle time and minimize the resources spent by drug discovery companies. The company utilizes proprietary Natural Language Processing based tools to extract, curate and annotate key biomedical information from literature and databases. Molecular Connections is currently applying its technology to extract bio-molecular interactions from literature, particularly protein-protein, gene-drug, DNA-protein interactions and has developed the most comprehensive database of protein-protein interactions from literature.

Triesta BioSciences is a privately owned clinical genomics company, which undertakes clinical and molecular evaluation validation of new targets and markers in partnership with international diagnostics and pharmaceutical companies. Triesta has disease programs in the areas of oncology, infectious diseases, gastrointestinal disorders and renal disease.

Post Your Comment

 

Enquiry Form